VDX‐111, a novel small molecule, induces necroptosis to inhibit ovarian cancer progression is a research paper published in Molecular Carcinogenesis (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Department of Defense
Grant: OC200302
NIH SPARK-REACH
Grant: MA 2022-2019
NCI NIH HHS
Grant: P30 CA046934
Department of Defense
Grant: OC200225
NIH/NCI
Grant: R37CA261987
NHLBI NIH HHS
Grant: U01 HL152405
NIH/NCI SBIR award
Grant: 1R44-CA250674
State of Colorado Office of Economic Development and International Trade Early-Stage Capital Retention award
Grant: CTGG1-2022-2820
Department of Defense
Grant: OC170228
NCI NIH HHS
Grant: R00 CA194318
NCI NIH HHS
Grant: R01 CA285446
NCI NIH HHS
Grant: R44 CA250674
NIH HHS
American Cancer Society
Ovarian Cancer Research Alliance
University of Colorado Gynecologic Oncology Fellowship
U.S. Department of Defense
National Institutes of Health
FWCI
1.72
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals